期刊文献+

缺氧对乳腺癌细胞E-cadherin、cytokeratin、vimentin表达的影响 被引量:1

Effect of hypoxia on E-Cadherin, Cytokeratin and Vimentin in breast cancer cell MCF7
下载PDF
导出
摘要 目的:研究体外缺氧对乳腺癌细胞系MCF7浸润能力及其细胞表面黏附分子E-cadherin和细胞骨架蛋白犤细胞角蛋白(cytokeratin)、波形蛋白(vimentin)犦表达的影响。方法:模拟体外缺氧环境,观察缺氧对乳腺癌细胞MCF7浸润穿透Matrigel的能力;以及采用半定量RT-PCR检测细胞表面黏附分子E-cadherin和cytokeratin、vimentin表达情况。结果:缺氧状态下MCF7细胞的浸润能力明显增强;且在缺氧条件下E-cadherin基因表达下降、cytokeratin、vimentin基因表达升高。结论:缺氧状态下MCF7细胞转移能力和其表面的E-cadherin基因、cytokeratin、vimentin基因表达存在一定关系。 Objective To study the effect of hypoxia on breast cancer cell MCF7 invasion through Matrigel and the underlying molecular mechanisms by regulating E-cadherin, eytokeratin and vimentin mRNA level in vitro. Methods We performed in vitro Matrigel invasion assay to study MCF7 cell invasion under an imitated hypoxic condition and determined the mRNA level of E-Cadherin, Cytokeratin and Vimentin by RT-PCR. Results Hypoxia could significantly promote MCF7 cells to invade through Matfigel; in addition, E-cadhefin was down-regulated while cytokeratin and vimentin were up-regulated under the hypoxic condition, Conclusion The aggressiveness of breast cancer cell MCF7 was related to the mRNA levels of E-eadherin, cytokeratin and vimentin under the hypoxic condition,
出处 《实用医学杂志》 CAS 2006年第10期1109-1111,共3页 The Journal of Practical Medicine
关键词 乳腺肿瘤 细胞系 肿瘤 缺氧 基因 肿瘤浸润 Breast neoplasms Cell line, tumor Anoxia Gene Neaplasm invasiveness
  • 相关文献

参考文献8

  • 1BIRCHMEIER W,BEHRENS J.Cadherin expression in carcinomas:role in the formation of cell junctions and the prevention of invasiveness[J].Biochim Biophys Acta,1994,1198(1):11-26.
  • 2UENISHI T,KUBO S,YAMAMOTO T,et al.Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence[J].Cancer Sci,2003,94(10):851-857.
  • 3THIERY J P.Epithelial-mesenchymal transitions in tumour progression[J].Nat Rev Cancer,2002,2(6):442 -454.
  • 4SINGH S,SADACHARAN S,SU S,et al.Overexpression of vimentin:role in the invasive phenotype in an androgen-independent model of prostate cancer[J].Cancer Res,2003,63(9):2306-2311.
  • 5IMAI T,HORIUCHI A,WANG C,et al.Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells[J].Am J Pathol,2003,163 (4):1437-1447.
  • 6GUDJONSSON T,VILLADSEN R,NIELSEN H L,et al.Isolation,immortalization,and characterization of a human breast epithelial cell line with stem cell properties[J].Genes Dev,2002,16(6):693 -706.
  • 7HENDRIX M J,SEFTOR E A,SEFTOR R E,et al.Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior[J].Am J Pathol,1997,150(2):483-495.
  • 8GILLES C,POLETTE M,MESTDAGT M,et al.Transactivation of vimentin by beta-catenin in human breast cancer cells[J].Cancer Res,2003,63(10):2658-2664.

同被引文献16

  • 1范钰,郑树,丁佳逸.脂质体介导的cripto反义寡核苷酸抑制结肠癌细胞端粒酶活性[J].中国病理生理杂志,2006,22(4):762-765. 被引量:42
  • 2Bianco C, Mysliwiec M, Watanabe K, et al. Activation of a Nodalindependent signaling pathway by Cripto-1 mutants with impaired activation of a Nodal-dependent signaling pathway. FEBS Lett, 2008, 582(29) :3997-4002.
  • 3Gray PC, Harrison CA, Vale W. Cripto form a complex with activin and Type Ⅱ activin receptors and can block activin signaling. Proc Natl Acad Sci U S A,2003,100(9) :5193-5198.
  • 4Strizzi L, Bianco C, Normanno N, et al. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J Cell Physiol, 2004, 201 (2) :266-276.
  • 5Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene, 2008,27 ( 55 ) : 6958-6969.
  • 6Tepass U, Truong K, Godt D, et al. Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol, 2000, 1 (2) :91- 100.
  • 7Cavallaro U, Schaffhauser B, Chrostofori G. Cadherin and the tumour progression:is it all in a switch? Cancer Lett, 2002,176 (2) :123-128.
  • 8Strizzi L, Postovit LM, Margaryan NV, et al. Emerging roles of nodal and Cripto-1 : from embryogenesis to breast cancer progression. Breast Dis, 2008,29:91-103.
  • 9Xing PX, Hu XF, Pietersz GA, et al. Cfipto: a novel target for antibody-based eaneer immunotherapy. Cancer Res, 2004, 64 (11) : 4018-4023.
  • 10Normanno N, De Luca A, Maiello MR, et al. CRIPTO-1 : a novel target for therapeutic intervention in human carcinoma. Int J Oncol, 2004,25 ( 4 ) : 1013-1020.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部